Cite

    E Hilton et al.. “P272 Improvements in exacerbation rates with single inhaler triple therapy versus dual ics/laba therapy in patients with advanced chronic obstructive pulmonary disease (copd): subgroup analyses of the phase iii fulfil study.” Thorax, vol. 72, n.d., p. A231. http://access.bl.uk/ark:/81055/vdc_100137789714.0x000024